US Edition7 Articles
7 Articles
I was 13 weeks pregnant when I agreed to the test. Then I got a shocking message from the hospital.
Simple cfRNA Test Detects Preeclampsia Months Before Onset
New research by scientists at the non-profit organization the Carlos Simón Foundation and the biotech company iPremom in Valencia, Spain, has revealed that a simple test of maternal blood plasma, called cell-free RNA (cfRNA) liquid biopsy, can help predict early-onset and late-onset preeclampsia five months before it is clinically diagnosed. Preeclampsia is a high blood pressure disorder that can develop in the second trimester of pregnancy, wi…
The current methods of detection of preeclampsia are based on risk factors and biomarkers of placenta. This causes them to fail in half of the cases and detect the disease when it has already begun to develop. To solve this, the Carlos Simón Foundation and the company Iprenom used a technique called liquid biopsy that analyzes fragments of RNA free of cells in maternal plasma and captures very subtle molecular signals. A precise test They enroll…
Scienmag: Latest Science and Health News
BIOENGINEER.ORGNew Study Reveals Simple Blood Test Can Predict Preeclampsia Risk Months
A groundbreaking study unveiled at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) this week marks a new era in prenatal care, revealing that a simple blood test conducted during the first trimester of pregnancy can predict the development of preeclampsia months before any clinical symptoms arise. This molecular “liquid biopsy” uses cell-free RNA (cfRNA) extracted from maternal plasma to detect subtle…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
To view factuality data please Upgrade to Premium
